Page last updated: 2024-10-28

hydroxyurea and Brachial Paresis

hydroxyurea has been researched along with Brachial Paresis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Default of therapy for polycythemia is associated with a profound risk of recurrent strokes requiring patient education and support to prevent the devastating consequence of this modifiable but rare cause of stroke."1.51Recurrent Stroke in a Ghanaian Patient With Polycythemia. ( Berchie, PO; Opare-Sem, OK; Ovbiagele, B; Sarfo, FS, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berchie, PO1
Sarfo, FS1
Opare-Sem, OK1
Ovbiagele, B1
Schmugge, M1
Frischknecht, H1
Yonekawa, Y1
Baumgartner, RW1
Boltshauser, E1
Humbert, J1

Other Studies

2 other studies available for hydroxyurea and Brachial Paresis

ArticleYear
Recurrent Stroke in a Ghanaian Patient With Polycythemia.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:3

    Topics: Aphasia, Broca; Aspirin; Clopidogrel; Ghana; Humans; Hydroxyurea; Infarction, Middle Cerebral Artery

2019
Stroke in hemoglobin (SD) sickle cell disease with moyamoya: successful hydroxyurea treatment after cerebrovascular bypass surgery.
    Blood, 2001, Apr-01, Volume: 97, Issue:7

    Topics: Anemia, Sickle Cell; Aphasia; Blood Flow Velocity; Blood Transfusion; Brain Damage, Chronic; Brain I

2001